Home
Conditions
Bone Marrow Diseases

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 528 recruiting studies

Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Jaktinib Versus Hydroxycarbamide in Subjects With Intermediate-2 or High-risk Myelofibrosis

NCT04617028

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: The First Affiliated Hospital of Medical School of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Completed

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

NCT03613727

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +20 more
Locations: Virginia Commonwealth University/ Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

NCT02639559

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +38 more
Locations: Northside Hospital Cancer Institute Atlanta, Georgia, United States

Washington University School of Medicine St Louis, Missouri, United States

Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)

NCT00167219

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies

NCT01823198

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, +36 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

NCT04055844

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +9 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

Washington University Medical School St Louis, Missouri, United States

University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.

NCT04851535

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Completed

Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT

NCT02989844

Conditions: Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

A Study of Pevonedistat in Adult East Asian Participants

NCT02782468

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Maebashi, Japan

Nagoya, Japan

Sendai, Japan

Tokyo, Japan

View Trial Details

Completed

Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial)

NCT01693601

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Bone Marrow Diseases

Bone Marrow Diseases trial results

Related conditions